These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Histone deacetylase inhibitors reduce VEGF production and induce growth suppression and apoptosis in human mantle cell lymphoma. Heider U, Kaiser M, Sterz J, Zavrski I, Jakob C, Fleissner C, Eucker J, Possinger K, Sezer O. Eur J Haematol; 2006 Jan; 76(1):42-50. PubMed ID: 16343270 [Abstract] [Full Text] [Related]
5. The insulin-like growth factor receptor 1 is a promising target for novel treatment approaches in neuroendocrine gastrointestinal tumours. Höpfner M, Baradari V, Huether A, Schöfl C, Scherübl H. Endocr Relat Cancer; 2006 Mar; 13(1):135-49. PubMed ID: 16601284 [Abstract] [Full Text] [Related]
6. Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis. Wetzel M, Premkumar DR, Arnold B, Pollack IF. J Neurosurg; 2005 Dec; 103(6 Suppl):549-56. PubMed ID: 16383255 [Abstract] [Full Text] [Related]
10. Histone deacetylase inhibitors differentially mediate apoptosis in prostate cancer cells. Frønsdal K, Saatcioglu F. Prostate; 2005 Feb 15; 62(3):299-306. PubMed ID: 15389787 [Abstract] [Full Text] [Related]
11. A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells. Ahn MY, Jung JH, Na YJ, Kim HS. Gynecol Oncol; 2008 Jan 15; 108(1):27-33. PubMed ID: 17920664 [Abstract] [Full Text] [Related]
13. Induction of apoptosis by trichostatin A, a histone deacetylase inhibitor, is associated with inhibition of cyclooxygenase-2 activity in human non-small cell lung cancer cells. Choi YH. Int J Oncol; 2005 Aug 15; 27(2):473-9. PubMed ID: 16010430 [Abstract] [Full Text] [Related]
14. Sulfonamide anilides, a novel class of histone deacetylase inhibitors, are antiproliferative against human tumors. Fournel M, Trachy-Bourget MC, Yan PT, Kalita A, Bonfils C, Beaulieu C, Frechette S, Leit S, Abou-Khalil E, Woo SH, Delorme D, MacLeod AR, Besterman JM, Li Z. Cancer Res; 2002 Aug 01; 62(15):4325-30. PubMed ID: 12154036 [Abstract] [Full Text] [Related]
15. Cell cycle arrest and lytic induction of EBV-transformed B lymphoblastoid cells by a histone deacetylase inhibitor, Trichostatin A. Seo JS, Cho NY, Kim HR, Tsurumi T, Jang YS, Lee WK, Lee SK. Oncol Rep; 2008 Jan 01; 19(1):93-8. PubMed ID: 18097580 [Abstract] [Full Text] [Related]
16. The novel inhibitor of histone deacetylase resminostat (RAS2410) inhibits proliferation and induces apoptosis in multiple myeloma (MM) cells. Mandl-Weber S, Meinel FG, Jankowsky R, Oduncu F, Schmidmaier R, Baumann P. Br J Haematol; 2010 May 01; 149(4):518-28. PubMed ID: 20201941 [Abstract] [Full Text] [Related]
17. Induction of apoptosis and inhibition of telomerase activity by trichostatin A, a histone deacetylase inhibitor, in human leukemic U937 cells. Woo HJ, Lee SJ, Choi BT, Park YM, Choi YH. Exp Mol Pathol; 2007 Feb 01; 82(1):77-84. PubMed ID: 16574101 [Abstract] [Full Text] [Related]
18. Use of a novel histone deacetylase inhibitor to induce apoptosis in cell lines of acute lymphoblastic leukemia. Romanski A, Bacic B, Bug G, Pfeifer H, Gul H, Remiszewski S, Hoelzer D, Atadja P, Ruthardt M, Ottmann OG. Haematologica; 2004 Apr 01; 89(4):419-26. PubMed ID: 15075075 [Abstract] [Full Text] [Related]
19. Evaluation of the in vitro and in vivo antitumor activity of histone deacetylase inhibitors for the therapy of retinoblastoma. Dalgard CL, Van Quill KR, O'Brien JM. Clin Cancer Res; 2008 May 15; 14(10):3113-23. PubMed ID: 18483379 [Abstract] [Full Text] [Related]
20. The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Hsi LC, Xi X, Lotan R, Shureiqi I, Lippman SM. Cancer Res; 2004 Dec 01; 64(23):8778-81. PubMed ID: 15574791 [Abstract] [Full Text] [Related] Page: [Next] [New Search]